Yaz Birth Control Pill Updates

Federal health experts said Thursday that drug labels for the update and other widely used birth control pills Yaz birth control pill (Who is Yaz?) should, according to recent data show an increased risk of blood clots with  Yaz birth control pill oldest contraceptive (What are birth control pills?).

The Food and Drug Administration, the jury voted 21-5 on Thursday to mark the popular  Yaz birth control pill from Bayer is insufficient and need more information about the possible risk of blood clots in the legs and lungs.

Yaz birth control pill, the use of his predecessors  Yaz birth control pill and related provisions of an artificial hormone called drospirenone, which mimics the natural hormone progesterone for women. Approved  Yaz birth control pill in 2006 became the most pickups sold in the U.S. for 2008, with the support of hundreds of millions of dollars advertising on television and magazines, their ability to resolve tensions and other effects secondary hormonal acne. However, revenues fell by more than 80 percent over the last two years because of security fears of Yaz birth control pill.

The panelists spent more than nine hours of discussion, often contradictory data on the risk of blood clots  Yaz birth control pill containing drospirenone compared to older drugs. While the group did not agree on the quality of the evidence, the vast majority said it should be clearly indicated on the label, including potentially fatal blood clots from Yaz birth control pill.

"Obviously, the text is inadequate and incomplete," said Dr. Richard Bockman New York Hospital for Special Surgery. "Adverse events should be taken to doctors and patients are aware of the consequences graphics."

In a vote earlier panelists voted 15-11 that the  Yaz birth control pill are still a useful option for preventing pregnancy. The majority decision amounts to a vote of confidence for the storage of drugs on the market, but also about a third of panel members voted against the Yaz birth control pill system as a whole, based on a set of alternatives available .

"I can not really a group of patients with Yaz birth control pill benefits compared to existing alternatives," said Mark Woods of the New York University School of Medicine. "Without a clear advantage, and taking account of the potentially catastrophic I have not. "

Two major studies by the German pharmaceutical company Bayer, no difference in blood clots in patients taking the drug companies and patients who have shown the older  Yaz birth control pill.

However, since 2009, five major studies have suggested that Yaz birth control pill containing drospirenone have a slightly increased risk of blood clots than older birth control pills, even if the events are very rare in both groups. Even a small increase in risk can be critical, because blood clots can cause heart attack, stroke and blockages in the lungs or blood vessels.